acefylline has been researched along with Extravascular Hemolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, S; Gul Khan, S; Parveen, B; Rasul, A; Shahzadi, I; Zahid, FM; Zahoor, AF | 1 |
| Anjum, MN; Irfan, A; Kotwica-Mojzych, K; Mansha, A; Mojzych, M; Rasul, A; Shahzadi, I; Tüzün, B; Zahoor, AF | 1 |
2 other study(ies) available for acefylline and Extravascular Hemolysis
| Article | Year |
|---|---|
In-vitro cytotoxic evaluation, hemolytic and thrombolytic potential of newly designed acefylline based hydrazones as potent anticancer agents against human lung cancer cell line (A549).
Topics: Antineoplastic Agents; Cell Line, Tumor; Hemolysis; Humans; Hydrazones; Lung Neoplasms; Structure-Activity Relationship; Theophylline | 2022 |
Repositioning of acefylline as anti-cancer drug: Synthesis, anticancer and computational studies of azomethines derived from acefylline tethered 4-amino-3-mercapto-1,2,4-triazole.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Repositioning; Drug Screening Assays, Antitumor; Hemolysis; Humans; Liver Neoplasms; Molecular Structure; Structure-Activity Relationship; Triazoles | 2022 |